---
title: Finerenone in Heart Failure with Mildly Reduced or Preserved Ejection Fraction
date: '2024-09-03'
linkTitle: https://pubmed.ncbi.nlm.nih.gov/39225278/?utm_source=curl&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1LIK-026Y9bjRE4xDQ231BSa89BnY4O2Rfi-9WXQd8C31C6cqE&fc=20211015124055&ff=20240904183702&v=2.18.0.post9+e462414
source: N Engl J Med
description: 'CONCLUSIONS: In patients with heart failure and mildly reduced or preserved
  ejection fraction, finerenone resulted in a significantly lower rate of a composite
  of total worsening heart failure events and death from cardiovascular causes than
  placebo. (Funded by Bayer; FINEARTS-HF ClinicalTrials.gov number, ...'
disable_comments: true
---
CONCLUSIONS: In patients with heart failure and mildly reduced or preserved ejection fraction, finerenone resulted in a significantly lower rate of a composite of total worsening heart failure events and death from cardiovascular causes than placebo. (Funded by Bayer; FINEARTS-HF ClinicalTrials.gov number, ...